who makes the glp 1 drugs GLP-1 are often misunderstood. They are not “celebrity weight loss injections.” They are result of 40 years of metabolic research and may change how we treat obesity, diabetes, and aging FDA says that the GLP-1
Description
SKK is the holder of the Evelyn Wyrzykowski Research Chair in Cardiology, Section of Cardiology, Department of Internal Medicine, University of Manitoba

King A, Miller EM

In diabetic mice, semaglutide alleviated anxiety- and depression-like behaviors and improved cognitive performance via modulation of the microbiota-gut-brain axis ( In summary, accumulating evidence supports the potential of GLP-1RAs in treating neurodegenerative and psychosocial disorders

doi: 10.1111/dom.13326 [DOI] [PubMed] [Google Scholar] 180.Elkeeb R, Eid T, Yu J, Nguyen H, Atef E
